Abstract
The global shortage of organs for transplantation represents a persistent ethical and logistical challenge for healthcare systems, including in Brazil, where supply still falls short of demand, resulting in long waiting lists and high morbidity and mortality among patients. In this context, xenotransplantation - the use of animal-derived organs, tissues, or cells in humans - emerges as a …